BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20679904)

  • 1. A new PPI, ilaprazole compared with omeprazole in the treatment of duodenal ulcer: a randomized double-blind multicenter trial.
    Wang L; Zhou L; Lin S; Hu H; Xia J
    J Clin Gastroenterol; 2011 Apr; 45(4):322-9. PubMed ID: 20679904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
    Wang L; Zhou L; Hu H; Lin S; Xia J
    Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, parallel, double-blind comparison of the ulcer-healing effects of ilaprazole and omeprazole in the treatment of gastric and duodenal ulcers.
    Ho KY; Kuan A; Zaño F; Goh KL; Mahachai V; Kim DY; Yoon HM
    J Gastroenterol; 2009; 44(7):697-707. PubMed ID: 19434360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
    Jensen DM; Pace SC; Soffer E; Comer GM;
    Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
    Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the effect of ilaprazole on intragastric pH in patients with duodenal ulcer].
    Zhou LY; Lin SR; Yang YS; Zhang ST; Yuan YZ; Shi RH; Hou XH; Xia JL; Hu HT; Qin XH
    Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):290-2. PubMed ID: 20627032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
    Schepp W; Classen M
    Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W; Rehner M; Witzel L
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
    Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
    Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical importance of proton pump inhibitor pharmacokinetics.
    Yacyshyn BR; Thomson AB
    Digestion; 2002; 66(2):67-78. PubMed ID: 12428065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
    Leonhardt U; Ritzel U; Ramadori G
    Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
    [No Abstract]   [Full Text] [Related]  

  • 14. A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
    Cremer M; Lambert R; Lamers CB; Delle Fave G; Maier C
    Dig Dis Sci; 1995 Jun; 40(6):1360-4. PubMed ID: 7781461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protonix. First i.v. proton pump inhibitor approved.
    Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
    [No Abstract]   [Full Text] [Related]  

  • 16. Lansoprazole--a new proton pump inhibitor.
    Ahmed W; Ali A; Qureshi H; Zuberi SJ; Shamsi ZU
    J Pak Med Assoc; 1995 May; 45(5):144-5. PubMed ID: 7563582
    [No Abstract]   [Full Text] [Related]  

  • 17. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of controloc in the treatment of acid-dependent diseases].
    Chubenko SS; Gaĭdukov VO; Agibalov AN; Onishenko AV
    Lik Sprava; 2003 Dec; (8):103-4. PubMed ID: 14965022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stubborn reflux pain, inconspicuous esophagus. Which therapy brings the fastest relief?].
    MMW Fortschr Med; 2004 Mar; 146(11):54. PubMed ID: 15152770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.